Unlike the qualitative analysis of conventional immunohistochemistry, multi-fluorescence immunohistochemistry technology has made technological innovations in multi-label staining, spectral imaging, and intelligent analysis, overcoming the limitations of traditional pathological single-label and qualitative analysis, as well as the technical shortcomings of gene expression profiling and flow cytometry that cannot obtain in situ spatial information of proteins and cells
It has a long half-life (~610 days when modified with DAC), allowing for sustained GH stimulation over time
Endocrinology 129 , 14021408 (1991)
Side Effects and Precautions: Dizziness, increased body temperature, water retention (edema), headache, injection site reactions (e.g., redness, itching), increased hunger, lower blood sugar levels
Kubo, H., et al